Evidence map›Paper›PMID 36889357›Full record

ReviewJournal of economic entomology2023

Prospects for classical biological control of Spodoptera frugiperda (Lepidoptera: Noctuidae) in invaded areas using parasitoids from the Americas.

Marc Kenis

Abstract readReview
In one paragraph

Review in Journal of economic entomology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Effect ofInsects · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Marc KenisCABI, Rue des Grillons 1, 2800 Delémont, Switzerland.ORCID 0000-0002-3179-0872

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fall armyworm, Spodoptera frugiperda (J.E. Smith) is a polyphagous agricultural pest threatening food security worldwide. This American species recently invaded most of Africa, many Asian countries, and Oceania, where it mainly damages maize. Classical biological control (CBC) through the introduction of natural enemies from its area of origin is considered as a potential management approach. The paper reviews the prospects and constraints of a CBC programme against S. frugiperda using larval parasitoids, which are considered the most suitable natural enemies for introduction against this pest. The most important larval parasitoids in its native range are presented and discussed for their suitability as CBC agents, based the following criteria: their frequency of occurrence and parasitism levels, specificity, climatic suitability and absence of closely related species parasitizing S. frugiperda in the area of introduction. The ichneumonid Eiphosoma laphygmae Costa-Lima (Hymenoptera: Icheumonidae) is considered as a potential candidate for introduction because of its specificity and its importance as a parasitoid of the pest in most of its native range. The most frequent and important parasitoid of S. frugiperda in the Americas, the braconid Chelonus insularis Cresson (Hymenoptera: Braconidae), would most probably contribute to the control of S. frugiperda if released in invaded areas. However, it is oligophagous and would most certainly parasitize nontarget species. Before introducing C. insularis, or any other parasitoid species, the potential nontarget effects will have to be assessed and the risks will have to be weighed against the benefits of improving the natural control of this important pest.

Indexed as

HymenopteraMothsAmericasAnimalsLarvaSpodopteraZea maysbiological controlbiological invasionparasitismparasitoidspecificity

Identifiers

PMID36889357
PMCPMC10125038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.